The World Economic Forum (WEF) has unveiled a significant report on the economic benefits of addressing women’s health issues. Named “Blueprint to Close the Women’s Health Gap,” this report posits that enhancing women’s health could potentially contribute around $400 billion to the global GDP by 2040. It highlights nine crucial health conditions that significantly impact women’s lives and emphasizes the necessity for targeted research and investment.
Understanding Women’s Health Disparities
Women endure 25% more years of poor health compared to their male counterparts, primarily due to a lack of dedicated research and financial support for women-specific health concerns. The report notes that women are frequently excluded from clinical trials, particularly in critical areas such as ischemic heart disease and migraine, where only 10% include data specific to sex.
Identified Key Health Conditions
The report classifies nine health conditions into two categories: lifespan conditions and health span conditions.
- Lifespan Conditions: These include maternal hypertensive disorders, postpartum hemorrhage, ischemic heart disease, cervical cancer, and breast cancer.
- Health Span Conditions: These focus on endometriosis, menopause, migraine, and premenstrual syndrome.
Tackling these health issues could potentially result in an additional 2.5 healthy days per woman each year.
Women’s Health Impact Tracking (WHIT)
In partnership with the McKinsey Health Institute, the WEF has launched the Women’s Health Impact Tracking (WHIT) platform. This public tool aims to assess health disparities and foster equitable solutions, offering data-driven insights that underscore the urgent need for investment in areas such as menopause, premenstrual syndrome, and migraine, collectively representing a $315 billion GDP opportunity.
The Necessity for Enhanced Data and Research
The report underscores the importance of improved data collection and funding for research focused specifically on women’s health issues. It highlights that 54% of the burden of women’s health is borne by individuals in low- and middle-income countries, while only 23% of clinical trials prioritize these regions. More comprehensive data is essential to uncover the true scope of women’s health challenges.
Essential Actions for Stakeholders
To bridge the disparity gap in women’s health, the report outlines five pivotal actions:
- Count Women: Enhance data collection processes to accurately reflect the true burden of women’s health challenges.
- Study Women: Increase funding for research focusing on women-specific health conditions.
- Care for Women: Develop clinical guidelines tailored to meet the unique healthcare needs of women.
- Include All Women: Address disparities faced by marginalized groups to promote health equity.
- Invest in Women: Direct funding towards innovative healthcare solutions and delivery models for women.
